litlas
ログインアカウント作成

David H. Johnson

1984–2025 年に発表

別表記
DAVID H. JOHNSON
157
論文数
58,808
被引用数
110
h 指数
152
i10 指数

被引用数

David H. Johnson の年別被引用数1943 年: 被引用 1 件1971 年: 被引用 2 件1985 年: 被引用 1 件1986 年: 被引用 2 件1987 年: 被引用 2 件1988 年: 被引用 3 件1989 年: 被引用 10 件1990 年: 被引用 11 件1991 年: 被引用 16 件1992 年: 被引用 32 件1993 年: 被引用 42 件1994 年: 被引用 38 件1995 年: 被引用 63 件1996 年: 被引用 42 件1997 年: 被引用 68 件1998 年: 被引用 56 件1999 年: 被引用 55 件2000 年: 被引用 69 件2001 年: 被引用 76 件2002 年: 被引用 125 件2003 年: 被引用 229 件2004 年: 被引用 284 件2005 年: 被引用 484 件2006 年: 被引用 520 件2007 年: 被引用 597 件2008 年: 被引用 558 件2009 年: 被引用 709 件2010 年: 被引用 645 件2011 年: 被引用 580 件2012 年: 被引用 537 件2013 年: 被引用 549 件2014 年: 被引用 424 件2015 年: 被引用 414 件2016 年: 被引用 418 件2017 年: 被引用 350 件2018 年: 被引用 312 件2019 年: 被引用 991 件2020 年: 被引用 955 件2021 年: 被引用 802 件2022 年: 被引用 578 件2023 年: 被引用 335 件2024 年: 被引用 544 件2025 年: 被引用 211 件2026 年: 被引用 8 件1944〜1970 年は被引用が無いため表示していません1972〜1984 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 4,632 件、この内訳の 30.5%中国: 引用元論文 1,397 件、この内訳の 9.2%イギリス: 引用元論文 863 件、この内訳の 5.7%日本: 引用元論文 712 件、この内訳の 4.7%カナダ: 引用元論文 690 件、この内訳の 4.5%イタリア: 引用元論文 683 件、この内訳の 4.5%ドイツ: 引用元論文 677 件、この内訳の 4.4%フランス: 引用元論文 590 件、この内訳の 3.9%オランダ: 引用元論文 481 件、この内訳の 3.2%スペイン: 引用元論文 438 件、この内訳の 2.9%オーストラリア: 引用元論文 336 件、この内訳の 2.2%韓国: 引用元論文 317 件、この内訳の 2.1%
0%30.5%その他 22.2%

機関

分野

  • Medicine72.8%
  • Biochemistry, Genetics and Molecular Biology18.3%
  • Immunology and Microbiology1.9%
  • Health Professions1.1%
  • Computer Science0.9%
  • Engineering0.7%
  • その他4.3%

トピック

  • Lung Cancer Treatments and Mutations10.7%
  • Lung Cancer Research Studies6.4%
  • Lung Cancer Diagnosis and Treatment6.2%
  • Cancer Immunotherapy and Biomarkers3%
  • Colorectal Cancer Screening and Detection2%
  • Colorectal Cancer Treatments and Studies1.9%
  • その他69.8%

共著者

全論文

検索で開く
  1. Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer

    著者: Alan Sandler, Robert J. Gray, Michael C. Perry, Julie R. Brahmer, Joan H. Schiller, Afshin Dowlati, Rogério Lilenbaum, David H. Johnson - New England Journal of Medicine 2006 被引用: 5,778

  2. Therapy for Stage IV Non–Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline Update

    著者: Nasser H. Hanna, Bryan J. Schneider, Sarah Temin, Sherman Baker, Julie R. Brahmer, Peter M. Ellis, Laurie E. Gaspar, Rami Y. Haddad, Paul J. Hesketh, Dharamvir Jain, Ishmael Jaiyesimi, David H. Johnson, Natasha B. Leighl, Tanyanika Phillips, Gregory J. Riely, Andrew Robinson, Rafael Rosell, Joan H. Schiller, Navneet Singh, David R. Spigel, Janis O. Stabler, Joan Tashbar, Gregory A. Masters - Journal of Clinical Oncology 2020 被引用: 455

  3. Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung Cancer

    著者: Joan H. Schiller, David Harrington, Chandra P. Belani, Corey J. Langer, Alan Sandler, James E. Krook, Junming Zhu, David H. Johnson - New England Journal of Medicine 2002 被引用: 4,984

  4. Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial

    著者: Kathy S. Albain, Ruth Swann, Valerie W. Rusch, Andrew T. Turrisi, Frances A. Shepherd, Colum J Smith, Yuhchyau Chen, Robert B. Livingston, Richard H. Feins, David R. Gandara, Willard A. Fry, Gail Darling, David H. Johnson, Mark R. Green, Robert C. Miller, Joanne Ley, W. Sause, James D. Cox - The Lancet 2009 被引用: 1,474

  5. Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations: ASCO and OH (CCO) Joint Guideline Update

    著者: Nasser H. Hanna, Andrew Robinson, Sarah Temin, Sherman Baker, Julie R. Brahmer, Peter M. Ellis, Laurie E. Gaspar, Rami Y. Haddad, Paul J. Hesketh, Dharamvir Jain, Ishmael Jaiyesimi, David H. Johnson, Natasha B. Leighl, Pamela R. Moffitt, Tanyanika Phillips, Gregory J. Riely, Rafael Rosell, Joan H. Schiller, Bryan J. Schneider, Navneet Singh, David R. Spigel, Joan Tashbar, Gregory A. Masters - Journal of Clinical Oncology 2021 被引用: 301

  6. Therapy for Stage IV Non–Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline

    著者: Navneet Singh, Sarah Temin, Sherman Baker, Elizabeth Blanchard, Julie R. Brahmer, Paul Celano, Narjust Duma, Peter M. Ellis, Ivy B. Elkins, Rami Y. Haddad, Paul J. Hesketh, Dharamvir Jain, David H. Johnson, Natasha B. Leighl, Hirva Mamdani, Gregory A. Masters, Pamela R. Moffitt, Tanyanika Phillips, Gregory J. Riely, Andrew Robinson, Rafael Rosell, Joan H. Schiller, Bryan J. Schneider, David R. Spigel, Ishmael Jaiyesimi - Journal of Clinical Oncology 2022 被引用: 124

  7. Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline

    著者: Navneet Singh, Sarah Temin, Sherman Baker, Elizabeth Blanchard, Julie R. Brahmer, Paul Celano, Narjust Duma, Peter M. Ellis, Ivy B. Elkins, Rami Y. Haddad, Paul J. Hesketh, Dharamvir Jain, David H. Johnson, Natasha B. Leighl, Hirva Mamdani, Gregory A. Masters, Pamela R. Moffitt, Tanyanika Phillips, Gregory J. Riely, Andrew Robinson, Rafael Rosell, Joan H. Schiller, Bryan J. Schneider, David R. Spigel, Ishmael Jaiyesimi - Journal of Clinical Oncology 2022 被引用: 113

  8. Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps, 2008: A Joint Guideline From the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology

    著者: Bernard Levin, David A. Lieberman, Beth G. McFarland, Kimberly Andrews, Durado Brooks, John H. Bond, Chiranjeev Dash, Francis M. Giardiello, Seth N. Glick, David H. Johnson, C. Daniel Johnson, Theodore R. Levin, Perry J. Pickhardt, Douglas K. Rex, Robert A. Smith, Alan G. Thorson, Sidney J. Winawer - Gastroenterology 2008 被引用: 3,007

  9. Adjuvant chemotherapy for resected early-stage non-small cell lung cancer

    著者: Sarah Burdett, Jean‐Pierre Pignon, Jayne F. Tierney, Hélène Tribodet, Lesley Stewart, C. Le Péchoux, Anne Aupérin, Thierry Le Chevalier, Richard Stephens, R. Arriagada, Julian P. T. Higgins, David H. Johnson, Jan P. van Meerbeeck, Mahesh Parmar, Robert L. Souhami, Bengt Bergman, Jean-Yves Douillard, Ariane Dunant, Chiaki Endo, D.J. Girling, Harubumi Kato, Steven M. Keller, Hideki Kimura, Aija Knuuttila, Ken Kodama, Ritsuko Komaki, Mark G. Kris, Thomas E. Lad, Tommaso Claudio Mineo, Steven Piantadosi, Rafael Rosell, Giorgio V. Scagliotti, Lesley Seymour, Frances A. Shepherd, Richard Sylvester, Hirohito Tada, Fumihiro Tanaka, Valter Torri, David Waller, Ying Liang, for the Non-Small Cell Lung Cancer Collaborative Group - Cochrane Database of Systematic Reviews 2015 被引用: 366

  10. Twice-Daily Compared with Once-Daily Thoracic Radiotherapy in Limited Small-Cell Lung Cancer Treated Concurrently with Cisplatin and Etoposide

    著者: Andrew T. Turrisi, KyungMann Kim, Ronald H. Blum, William T. Sause, Robert B. Livingston, Ritsuko Komaki, Henry Wagner, Seena C. Aisner, David H. Johnson - New England Journal of Medicine 1999 被引用: 1,498

  11. Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data

    著者: R Arriagada, R. Arriagada, A. Aupérin, Sarah Burdett, Julian P. T. Higgins, David H. Johnson, Thierry Le Chevalier, C. Le Péchoux, M.K.B. Parmar, Jean‐Pierre Pignon, R L Souhami, Richard Stephens, Lesley Stewart, Jayne F. Tierney, Hélène Tribodet - The Lancet 2010 被引用: 630

  12. Factors influencing success of clinical genome sequencing across a broad spectrum of disorders

    著者: Jenny C. Taylor, Hilary C. Martin, Stefano Lise, John Broxholme, Jean‐Baptiste Cazier, Andy Rimmer, Alexander Kanapin, Gerton Lunter, Simon Fiddy, Chris Allan, A.R. Aricescu, Moustafa Attar, Christian Babbs, Jennifer Becq, David Beeson, Celeste Bento, P Bignell, Edward Blair, Veronica J. Buckle, Katherine R. Bull, Ondřej Cais, Holger Cario, Helen Chapel, Richard R. Copley, Richard J. Cornall, Jude Craft, Karin Dahan, Emma E. Davenport, Calliope A. Dendrou, Olivier Devuyst, Aimée L Fenwick, Jonathan Flint, Lars Fugger, Rodney D. Gilbert, Anne Goriely, Angie Green, Ingo H. Greger, Russell Grocock, Anja V. Gruszczyk, Robert Hastings, Edouard Hatton, Douglas R. Higgs, Adrian V. S. Hill, Chris Holmes, Malcolm F. Howard, Linda Hughes, Peter Humburg, David H. Johnson, Fredrik Karpe, Zoya Kingsbury, Usha Kini, Julian C. Knight, Jonathan Krohn, Sarah Lamble, Craig B. Langman, Lorne Lonie, Joshua Luck, Davis J. McCarthy, Simon J. McGowan, Mary Frances McMullin, Kerry A. Miller, Lisa Murray, Andrea H. Németh, M. Andrew Nesbit, David Nutt, Elizabeth Ormondroyd, Annette Oturai, Alistair T. Pagnamenta, Smita Y. Patel, Melanie J. Percy, Nayia Petousi, Paolo Piazza, Siân E. Piret, Guadalupe Polanco‐Echeverry, Niko Popitsch, Fiona Powrie, Christopher W. Pugh, Lynn Quek, Peter A. Robbins, Kathryn Robson, Alexandra Russo, Natasha Sahgal, Pauline A. van Schouwenburg, Anna Schuh, Earl D. Silverman, Alison Simmons, Per Soelberg Sørensen, Elizabeth Sweeney, John Taylor, Rajesh V. Thakker, Ian Tomlinson, Amy Trebes, Stephen R.F. Twigg, Holm H. Uhlig, Paresh Vyas, Tim J. Vyse, Steven A. Wall, Hugh Watkins, Michael P. Whyte, Lorna Witty ほか 10 名 - Nature Genetics 2015 被引用: 388

  13. Systemic Therapy for Stage IV Non–Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update

    著者: Nasser H. Hanna, David H. Johnson, Sarah Temin, Sherman Baker, Julie R. Brahmer, Peter M. Ellis, Giuseppe Giaccone, Paul J. Hesketh, Ishmael Jaiyesimi, Natasha B. Leighl, Gregory J. Riely, Joan H. Schiller, Bryan J. Schneider, Thomas J. Smith, Joan Tashbar, William A. Biermann, Gregory A. Masters - Journal of Clinical Oncology 2017 被引用: 650

  14. Impact of Cancer-Related Fatigue on the Lives of Patients: New Findings From the Fatigue Coalition

    著者: Gregory A. Curt, William Breitbart, David Cella, Jerome E. Groopman, Sandra J. Horning, Loretta M. Itri, David H. Johnson, Christine Miaskowski, Susan L. Scherr, Russell K. Portenoy, Nicholas J. Vogelzang - The Oncologist 2000 被引用: 1,253

  15. "Zen 4": The AMD 5nm 5.7GHz x86-64 Microprocessor Core

    著者: Benjamin Munger, Kathy Wilcox, Jeshuah Sniderman, Chuck Tung, Brett C. Johnson, Russell Schreiber, Carson Henrion, Kevin Gillespie, Tom Burd, Harry D. Fair, David H. Johnson, Jonathan M. White, Scott McLelland, Steven Bakke, Javin Olson, Ryan McCracken, Matthew D. Pickett, Aaron Horiuchi, Hien Nguyen, Tim H Jackson - IEEE International Solid- State Circuits Conference (ISSCC) 2023 被引用: 29

  16. Efficacy and safety of the monoclonal anti-tumor necrosis factor antibody F(ab′)2 fragment afelimomab in patients with severe sepsis and elevated interleukin-6 levels*

    著者: Edward A. Panacek, John C. Marshall, Timothy E. Albertson, David H. Johnson, Steven B. Johnson, Rodger D. MacArthur, Mark Miller, William Barchuk, Steven Fischkoff, Martin Kaul, Leah Teoh, Lori Van Meter, Lothar Daum, Stanley Lemeshow, Gregory A. Hicklin, Christopher J. Doig - Critical Care Medicine 2004 被引用: 384

  17. Systemic Therapy for Stage IV Non–Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update

    著者: Gregory A. Masters, Sarah Temin, Christopher G. Azzoli, Giuseppe Giaccone, Sherman Baker, Julie R. Brahmer, Peter M. Ellis, Ajeet Gajra, Nancy Rackear, Joan H. Schiller, Thomas J. Smith, John R. Strawn, David Trent, David H. Johnson - Journal of Clinical Oncology 2015 被引用: 851

  18. Randomized Phase II Trial Comparing Bevacizumab Plus Carboplatin and Paclitaxel With Carboplatin and Paclitaxel Alone in Previously Untreated Locally Advanced or Metastatic Non-Small-Cell Lung Cancer

    著者: David H. Johnson, Louis Fehrenbacher, William Novotny, Roy S. Herbst, John Nemunaitis, David M. Jablons, Corey J. Langer, Russell F. DeVore, Jacques Gaudreault, Lisa A. Damico, Eric Holmgren, Fairooz F. Kabbinavar - Journal of Clinical Oncology 2004 被引用: 1,950

  19. Trastuzumab in the Treatment of Advanced Non-Small-Cell Lung Cancer: Is There a Role? Focus on Eastern Cooperative Oncology Group Study 2598

    著者: Corey J. Langer, Patricia Stephenson, Ann D. Thor, Márk Vangel, David H. Johnson - Journal of Clinical Oncology 2004 被引用: 225

  20. Gefitinib in Combination With Gemcitabine and Cisplatin in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial—INTACT 1

    著者: Giuseppe Giaccone, Roy S. Herbst, Christian Manegold, Giorgio V. Scagliotti, Rafael Rosell, Vincent A. Miller, Ronald B. Natale, Joan H. Schiller, Joachim von Pawel, A Płużańska, U. Gatzemeier, John Grous, Judith Ochs, Steven D. Averbuch, Michael Wolf, Pamela Rennie, Abderrahim Fandi, David H. Johnson - Journal of Clinical Oncology 2004 被引用: 1,720

  21. Randomized Phase III Trial of Vinorelbine Plus Cisplatin Compared With Observation in Completely Resected Stage IB and II Non–Small-Cell Lung Cancer: Updated Survival Analysis of JBR-10

    著者: Charles Butts, Keyue Ding, Lesley Seymour, Philip Twumasi‐Ankrah, Barbara Graham, David R. Gandara, David H. Johnson, Kenneth A. Kesler, Mark A. Green, Mark Vincent, Yvon Cormier, Glenwood Goss, B. Findlay, Michael Johnston, Ming‐Sound Tsao, Frances A. Shepherd - Journal of Clinical Oncology 2009 被引用: 433

  22. Trajectories of Health Care Contact Days for Patients With Stage IV Non–Small Cell Lung Cancer

    著者: Arjun Gupta, Paul Nguyen, Danielle Kain, Andrew Robinson, Amit Kulkarni, David H. Johnson, Carolyn J. Presley, Anne Blaes, Gabrielle B. Rocque, Ishani Ganguli, Christopher M. Booth, Timothy P. Hanna - JAMA Network Open 2024 被引用: 28

  23. Body Mass Index and Its Association with Clinical Outcomes for Advanced Non–Small-Cell Lung Cancer Patients Enrolled on Eastern Cooperative Oncology Group Clinical Trials

    著者: Suzanne E. Dahlberg, Joan H. Schiller, Philip Bonomi, Alan B. Sandler, Julie R. Brahmer, Suresh S. Ramalingam, David H. Johnson - Journal of Thoracic Oncology 2013 被引用: 110

  24. A Meta-Analysis of Thoracic Radiotherapy for Small-Cell Lung Cancer

    著者: Jean‐Pierre Pignon, R. Arriagada, Daniel C. Ihde, David H. Johnson, Michael C. Perry, Robert L. Souhami, Ola Brodin, R Joss, Merrill S. Kies, B Lebeau, T Onoshi, Kell Østerlind, Martin H.N. Tattersall, Henry Wagner - New England Journal of Medicine 1992 被引用: 1,333